Lates News

According to the AI flash news every day, on December 4th, Southwest Securities issued a research report giving Dana Life Sciences (920009.SH) a "buy" rating. The rating reasons mainly include: 1) Rich products, sound qualifications, and technological innovation jointly build the company's moat; 2) Policy favorable matching product certification, domestic and international market potential jointly released. (Daily Economic News)